Lutsar, KatrinAlloja, JanikaOselin, KerstiRooväli, LiisNurk, KaarelKiivet, Raul-AllanJürisson, Mikk2022-11-072022-11-0720229789985413081http://hdl.handle.net/10062/87846Report in Estonian, summary in EnglishestopenAccessAttribution-NonCommercial-NoDerivatives 4.0 Internationaltervisetehnoloogiate hindaminehealth technology assessmenttervisetehnoloogianeeruvähkneerukasvajadEestiimmuunraviKaugelearenenud heledarakulise neeruvähi immuunravi kulutõhusus: tervisetehnoloogia hindamise raport TTH55Cost-effectiveness of immunotherapy in the treatment of advanced clear-cell renal carcinoma: health technology assessment report HTA55Technical Report